Filter below by day:
Grantsmanship Overview
Available:
APRIL 27
Learn key elements in crafting a strong proposal, review a sample proposal that was funded, and discuss strategies for revising and re-submitting non-funded proposals.
Stephen Hammes, MD, PhD
University of Rochester
Dr. Hammes graduated with a degree in Chemistry from Cornell University in 1985. He then received his MD/PhD from Duke University. After that, he moved to the University of California in San Francisco, where he completed an internship and residency in General Medicine, followed by a clinical and research fellowship in Endocrinology.
In 1999, Dr. Hammes joined the faculty at the University of Texas Southwestern Medical Center in Dallas, where he was a W W Caruth Scholar in Biomedical Research and Co-Director of the Endocrinology Fellowship Program. He moved to the University of Rochester in 2009 to become the Louis S Wolk Distinguished Professor of Medicine and the Chief of the Division of Endocrinology and Metabolism.
Dr. Hammes is interested in ovarian development and function. His laboratory studies steroid synthesis and actions in the ovary, with a focus on the pathophysiology of Polycystic Ovarian Syndrome. In addition, his lab studies androgen signaling in prostate cancer, focusing on nongenomic actions of androgens. Finally, he has an interest in lymphangioleiomyomatosis (LAM), a rare lung tumor that affects almost exclusively women. He has previously served as Editor-in-Chief of the journals Molecular Endocrinology and Endocrinology.
Disclosures:
No Relevant Financial Relationship
Individual Career Development Plans: A Strategy for Success
Available:
APRIL 27
Learn the importance of and tips on developing a strong individual development plan (IDP) based on your individual goals and career level. IDPs provide a structured career development tool that can be used to help identify and monitor short and long-term goals.
Genevieve Neal-Perry, MD, PhD
University of North Carolina at Chapel Hill
Dr. Neal-Perry received her Bachelor of Arts in Biology from Dartmouth College in 1988 and her MD PhD in Pharmacology from Robert Wood Johnson Medical School in 1998. She completed an Obstetrics and Gynecology residency at Beth Israel Medical Center in New York City, the Manhattan Campus for Einstein College of Medicine in 2002, and a subspecialty fellowship in Reproductive Endocrinology and Infertility (REI) at Montefiore Medical Center and Einstein College of Medicine in 2005. Dr. Neal-Perry was the Director of the REI fellowship training program (2011-2015) and the Associate Dean for Diversity Mentoring (2010-2015) while at Einstein College of Medicine. She moved to the University of Washington to join the department of Obstetrics and Gynecology in February 2015. While at the University of Washington, Dr. Neal-Perry served as the Division Chief for REI and the Section Director of the Onco-Reproduction Unit. Dr. Neal-Perry joined the University of North Carolina School of Medicine in April 20220 to serve as the Robert A. Ross Distinguished Professor and Chair of Obstetrics and Gynecology.
Dr. Neal-Perry is a leader in women’s healthcare and reproductive science. She serves as an ad hoc reviewer for more than 20 journals and she is an editorial board member for Endocrinology. She directs basic science as well as clinical research that is focused on the effect of age, hormones, metabolism and nutrition on neuroendocrine function, the pubertal and menopausal transition and the modifiers of menopause-related symptoms. She has published multiple original research articles, research abstracts, book chapters and review articles with her mentees and scientific peers. Her research has been recognized by Faculty of 1000 as important contributions to scientific literature (2009 and 2015). She was funded by Robert Wood Johnson Foundation, NIH, SREI, ASRM, the American Federation for Aging Research, and other private foundations. Dr. Neal-Perry’s current research program is funded by the NICHD and private foundations. She currently serves as the PI of the Women’s Reproductive Health Research Grant, a highly coveted NIH Mentored Research Scientist Development Program Award (K12) mechanism for physicians who have trained in Obstetrics and Gynecology.
Dr. Neal-Perry is currently the Vice President, Basic Science (2016-2019), for The Endocrine Society and a board member for the Division of Reproductive Endocrinology and Infertility of the American Board of Obstetrics and Gynecology. She is standing member of the NICHD Reproduction Andrology and Gynecology (2017-2021) study section and previously served as member of the Integrative Clinical Endocrinology and Reproduction (2012-2018) study section. She is currently the Vice President of Diversity and Structural Change for the Society of Reproductive Investigations and a member of the National Advisory Child Health and Human Development Council.
Dr. Neal-Perry is passionate about medical education and training of the next generation of clinicians and scientists. She has mentored high school through junior faculty mentees. Her mentees have successfully competed for independent grants and their research has been selected for plenary presentations at American Reproductive Society of Medicine and the Society of Reproductive Investigations. Dr. Neal-Perry has received mentor awards from the American Medical Women’s Association as well as the Endocrine Society.
Disclosures:
No Relevant Financial Relationship
Self-Awareness: The Key to Success in Life
Not Currently Available
Discover your personality type and communication style using the DiSC assessment.
Krista Kirk, SPHR, SHRM-SCP
Endocrine Society
Krista has a dual focus as the Chief of Staff and the head of Human Resources. As the Chief of Staff, she acts as an integrator by supporting the deployment of organizational priorities across the organization to enhance organizational performance in areas of organizational design, workflow process improvement team dynamics and structures for increased engagement. In the HR role, she strategically aligns the people strategy with the organizational strategy.
Krista has over 20 years’ experience in HR and organizational development and holds two certifications as a Senior Professional in Human Resources (SHRM-SCP, SPHR). She holds a BA in Communications from the University of North Carolina, Greensboro.
Disclosures:
No Relevant Financial Relationship
Building and Managing a Lab
Available:
APRIL 28
Discuss tips and pitfalls on setting up a lab, core facility access, release time from clinical/teaching duties, recruitment, and time management. This session will also cover tips on sharing information and protecting intellectual property
Lauren Fishbein, MD, PhD, MTR(Speaker)
University of Colorado School of Medicine
Lauren Fishbein, MD, PhD, MTR is an Associate Professor in Medicine at the University of Colorado School of Medicine in the Division of Endocrinology, Metabolism and Diabetes with a secondary appointment in the Division of Biomedical Informatics and Personalized Medicine. She received her bachelor’s degree in Biochemistry from Vassar College and earned her MD, PhD degree from the University of Florida with a PhD in Molecular Genetics. She completed her Internal Medicine Residency at Harvard’s Beth Israel Deaconess Medical Center in Boston and her Endocrinology Fellowship at the University of Pennsylvania where she also completed a Master’s in Translational Research. Dr. Fishbein has a strong research and clinical interest in personalized medicine including understanding the impacts and implications of germline endocrine cancer predisposition genetics, as well as interest in understanding neuroendocrine tumor development and transformation to aggressive and metastatic disease. The Endocrine Society is her professional home. She was Co-Chair of the Trainee and Career Development Core Committee and served as an Ex-Officio member on the Council (now Board of Directors). She is currently a member of the Annual Meeting Steering Committee. She has a passion for career development and for several years, she Chaired the Early Career Forum, the Career Development Workshops and the Summer Research Fellowship program.
Disclosures:
No Relevant Financial Relationship
Simon Rhodes, BSC, PhD(Speaker)
University of North Florida
Dr. Simon Rhodes is Professor of Biology at the University of North Florida (UNF). He was previously Provost and VP Academic Affairs at UNF, and before that Dean and Professor of Biology of the School of Science at Indiana University-Purdue University Indianapolis and Professor of Cellular & Integrative Physiology and Biochemistry & Molecular Biology at the Indiana University School of Medicine. Dr. Rhodes received a B.Sc. Hons. biochemistry from the University of Sheffield, U.K., the Ph.D. in biochemistry from Purdue University, and did postdoctoral work at the University of California San Diego. Dr. Rhodes’ research investigates the molecular basis of pediatric pituitary hormone deficiency diseases. Dr. Rhodes has served on the Endocrine Society Finance & Audit, Minority Affairs (now CoDI), and Trainee & Career Development committees. Dr. Rhodes recent awards include the Bepko Outstanding Administrator Award (from university Faculty Council), the IUPUI Chancellor’s Medallion, a Resolution of Appreciation from the Trustees of Purdue University, Norman Brown Diversity Scholars Program Mentor of the Year, Dr. Joseph T. Taylor Award for Excellence in Diversity, and Purdue University College of Science Outstanding Alumni Award.
Disclosures:
No Relevant Financial Relationship
Building Collaborative Research Teams
Available:
APRIL 28
Learn strategies to building and maintaining high-performing collaborative research teams through teamwork exercises that strengthen interpersonal skills and communication.
Glenn Rowe, PhD(Speaker)
University of Alabama at Birmingham
Dr. Glenn C. Rowe is a currently an Assistant Professor in the Department of Medicine within the Cardiovascular Division at the University of Alabama at Birmingham. The research interest of Dr. Rowe’s laboratory focuses on understanding the molecular pathways that influence mitochondrial metabolism in response to diet and exercise. Specifically, the lab studies the molecular pathways that regulate mitochondrial function in striated muscle using rodent models. Dr. Rowe received his B.S. in Biology from Brandeis University and his M.S. and Ph.D. in Molecular, Cellular and Developmental Biology from Yale University and completed his post-doctoral training at Beth Israel Deaconess Medical Center-Harvard Medical School. Dr. Rowe is also a FLARE alum.
Disclosures:
No Relevant Financial Relationship
Leonor Corsino, MD(Speaker)
Duke University
Dr. Leonor Corsino is a dual Board- Certified Internist and Adult Endocrinologist and an experienced physician-scientist, organizational and health professional education leader. Her expertise and strengths lie in her diverse portfolio that expands from basic science to clinical and community-engaged research, innovative curriculum development, successful clinical program implementation, and collaborations.
Dr. Corsino's research focuses on diabetes, obesity and related complications and health disparities with a particular interest in Hispanic/Latino populations. She has successfully led and extensively collaborates with investigators locally, nationally, and internationally. Her research and contribution have been recognized locally and at the national levels with many awards including the NIH/NIDDK Network of Minority Health Research Investigators medallion.
Dr. Corsino has extensive leadership experience including her current roles as Associate Dean of Students Affairs/Advisory Dean Duke School of Medicine MD program, member of the Executive Committee Member and Associate Director of the Duke School of Medicine Master of Biomedical Sciences (MBS), and Co-Director for the Duke Clinical and Translational Science Institute - Community Engagement Core / Community-Engaged Research Initiative (CERI).
Disclosures:
No Relevant Financial Relationship
Communication: Selling Yourself and Your Science
Not Currently Available
Gain practical tips on communicating your science to different audiences. Put into practice the skills learned in small group sessions.
Joshua Joseph, MD, MPH(Speaker)
Ohio State University Medical Center
Joshua J. Joseph, MD, MPH, FAHA is an Assistant Professor of Medicine in the Division of Endocrinology, Diabetes and Metabolism at The Ohio State University Wexner Medical Center (OSUWMC). He is Co-Chair of the OSUWMC Healthy Communities Obesity and Nutrition Steering Committee and a member of the Health Equity Steering Committee. Dr. Joseph’s National Institutes of Health and Robert Wood Johnson Foundation funded research focuses on advancing prevention and treatment of diabetes and cardiovascular disease through a health equity lens. He is Chair Elect of the Endocrine Society Clinical Affairs Core Committee.
Disclosures:
No Relevant Financial Relationship
Lindsey Starr Trevino, PhD(Speaker)
City of Hope National Medical Center
Lindsey S. Treviño, Ph.D. is an Assistant Professor in the Division of Health Equities and the Department of Population Sciences. Dr. Treviño received her doctorate in Reproductive Physiology from Cornell University. Her dissertation research focused on the role of steroid hormone receptor signaling in the development and/or progression of ovarian cancer in the hen. Dr. Treviño continued her postgraduate training at Baylor College of Medicine, where she investigated the regulation of progesterone receptor activity by cell signaling pathways in breast cancer cells. She received additional postdoctoral training at the Institute of Biosciences and Technology of Texas A&M University, where she examined the molecular basis of how developmental exposure to the endocrine disruptor bisphenol A (BPA) reprograms the liver epigenome to alter liver metabolism in adulthood in the rat. She continued this line of research as an Instructor at Baylor College of Medicine before joining City of Hope. Dr. Treviño’s current research program aims to investigate the molecular basis by which exposure to endocrine disrupting chemicals (EDCs) promotes the development and progression of hormone-sensitive cancers, particularly in the context of health inequities. Dr. Treviño has been selected as a Future Leaders Advancing Research in Endocrinology (FLARE) Fellow, a Keystone Symposia Fellow, a National Institutes of Health Future Research Leader, and as a recipient of the Young Investigator Award sponsored by the Women in Endocrinology. She previously served on the Committee on Diversity and Inclusion (CODI), on the Governance Task Force, and on the Research Affairs Core Committee (RACC) of the Endocrine Society. She currently serves on the Board of Directors of the Endocrine Society.
Disclosures:
No Relevant Financial Relationship
Self-Awareness Pt. 2: The Key to Success in Life
Not Currently Available
Identify strengths and stressors and how your style plays a role in teambuilding through interactive small group activities.
Krista Kirk, SPHR, SHRM-SCP
Endocrine Society
Krista has a dual focus as the Chief of Staff and the head of Human Resources. As the Chief of Staff, she acts as an integrator by supporting the deployment of organizational priorities across the organization to enhance organizational performance in are
Disclosures:
No Relevant Financial Relationship
Career Transitions and Navigating Your Next Steps
Not Currently Available
Gain tips on how to make your next transition as smooth as possible. Break out discussions will look closely at transitions from the student to fellow, fellow to early career faculty, and faculty considering different opportunities.
Cherié Butts, PhD(Speaker)
Biogen Inc.
Cherié Butts, PhD is Medical Director and Head of Clinical Assessments – Digital & Quantitative Medicine at Biogen (Cambridge, MA). She obtained undergraduate and graduate degrees from The Johns Hopkins University. Her pre-doctoral studies at University of Texas MD Anderson Cancer Center characterized immune responses in ovarian cancer patients and postdoctoral studies at National Institutes of Health examined neuroendocrine regulation of immunity. She continued research at US Food & Drug Administration, taking on additional responsibilities of evaluating drug applications. At Biogen, she is responsible for clinical trials and the use of tools for better understanding disease biology, reducing trial burden, and ensuring trials better represent all afflicted with disease.
She is passionate about the furtherance of biomedical research and works with professional societies, scientific/professional development organizations, and biomedical research institutions. She currently serves on the Leadership Board of Beth Israel Deaconess Medical Center; Board of Directors of Keystone Symposia; Board of Trustees at Salem State University; Council of the Society of Leukocyte Biology; Chan-Zuckerberg Initiative Scientific Advisory Board; American Association of Immunologists Committee on Public Affairs; Federation of American Societies for Experimental Biology Finance Committee and Taskforce on Emerging Issues/Revenue Opportunities (chair); and is Adjunct Professor at University of Maryland.
Disclosures:
Cherie Butts, PhD is employed with Biogen and receives a salary from the company. However, she will not be discussing the business lines or products of her employer in the context of this educational activity.
Ayotunde Dokun, MD, PhD(Speaker)
University of Iowa Hospitals and Clinics
Dr Dokun is an Associate Professor of Medicine and Endocrinology, and Director, Division of Endocrinology and Metabolism at the Carver School of Medicine, University of Iowa (UI). He received his Bachelor’s Degree in Biological Sciences from the State University of New York College at Old Westbury, Long Island, NY. He subsequently trained in the National Institute of Health (NIH) sponsored Medical Scientist Training Program (MSTP) at the Mt Sinai Graduate School of Biological Sciences and the Mt Sinai School of Medicine (now Icahn School of Medicine), New York, NY where he earned his MD and PhD. After completion of his graduate training, he entered residency in Internal Medicine and Fellowship training in Endocrinology and Metabolism at Duke University Medical Center, Durham, NC.
Dr Dokun is an alumnus of the prestigious Robert Wood Johnson Foundation (RWJF), Amos Medical Faculty Development Program (AMFDP). Along with his responsibilities as director of the Endocrine division at UI, he currently runs a translational research laboratory with a focus on understanding the molecular mechanisms of vascular complications in diabetes. He is well published, including publications in high profile Journals such as Science, Nature Immunology, Circulation and Circulation Research.
He has received a number of awards, including the Elijah B Saunders MD, Physician of the Year Award from the National Medical Association, the Terry Ann Krulwich, Physician-Scientist Alumni Award and the Jay D. Coffman Early Career Investigator Award from the American Heart Association (AHA).
Dr Dokun currently serves on the editorial board of a number of scientific journals and on the board of a non-for-profit organization. Recently he was appointed to serve on the National Clinical Care Commission, a Federal advisory commission focused on evaluating and making recommendations on existing federal programs related to diabetes and its complications.
Disclosures:
No Relevant Financial Relationship
Mark Roberson, PhD(Speaker)
Cornell University College of Vet Medical
Dr. Roberson was raised in the Sierra Nevada region of Northern California and attended Cal Poly, San Luis Obispo, earning a BS degree in Animal Science. He earned his PhD from the University of Nebraska in Animal Physiology in 1990 with a focus on reproductive biology. He spent five years in postdoctoral training with Dr. Richard Maurer at the medical colleges at the University of Iowa, Iowa City, IA and then Oregon Health and Sciences University, Portland OR focusing on molecular endocrinology, GnRH action and gonadotropin gene regulation. Dr. Roberson was recruited to Cornell University College of Veterinary Medicine initially to the Department of Physiology in 1995 as an Assistant Professor. In 1999, this department merged to become the Department of Biomedical Sciences. In 2001, Dr. Roberson was appointed Associate Professor with indefinite tenure. In 2007, he was appointed Chair of Biomedical Sciences and Professor of Physiology; he served as Chair until 2017 when he stepped down to rejoin the research and teaching faculty. Dr. Roberson currently serves as Director of Undergraduate Studies in Animal Physiology Dr. Roberson has been funded by the NICHD and USDA and also served as PI and Director of an NICHD-funded T32 Training Program in Reproductive Sciences and Genomics. The Roberson lab focuses on molecular endocrine studies of the neuroendocrine axis controlling fertility and development studies of the murine and human placentas.
Disclosures:
No Relevant Financial Relationship
Individual Career Development Presentations – Part 1
Not Currently Available
Participants will report out and receive faculty feedback on their short-term and long-term goals.
E. Dale Abel, MD, PhD(Speaker)
University of Iowa
E. Dale Abel, MD, PhD is the Chair and Department Executive Officer of the Department of Internal Medicine and Director of the Fraternal Order of Eagles Diabetes Research Center (FOEDRC) at the University of Iowa. He is a Professor of Medicine, of Biochemistry, and of Biomedical Engineering, and holds the John B. Stokes III Chair in Diabetes Research and the François M. Abboud Chair in Internal Medicine. Dr. Abel has had a distinguished career in endocrine and metabolism research. His pioneering work on glucose transport and mitochondrial metabolism in the heart guides his current research interests: molecular mechanisms responsible for cardiovascular complications of diabetes. His laboratory has provided important insights into the contribution of mitochondrial dysfunction and aberrant insulin signaling, to heart failure risk in diabetes. Recent work has focused on mitochondrial mechanisms that mediate inter-organ crosstalk that may influence the pathophysiology of insulin resistance and mitochondrial pathways linking metabolism with increased risk for atherothrombosis. Dr. Abel’s research program has been continually funded by the National Institutes of Health since 1995, and by the American Heart Association, the American Diabetes Association, and the Juvenile Diabetes Research Foundation. Dr. Abel is the recipient of numerous awards for scholarship and mentorship. He is an elected member of the American Association of Physicians (AAP), the American Society for Clinical Investigation (ASCI), National Academy of Medicine (NAM), and the American Clinical and Climatological Association (ACCA). Dr. Abel is President-elect of the Association of Professors of Medicine (APM) and the Immediate Past President of the Endocrine Society.
Disclosures:
No Relevant Financial Relationship
Stephen Hammes, MD, PhD(Speaker)
University of Rochester
Dr. Hammes graduated with a degree in Chemistry from Cornell University in 1985. He then received his MD/PhD from Duke University. After that, he moved to the University of California in San Francisco, where he completed an internship and residency in General Medicine, followed by a clinical and research fellowship in Endocrinology.
In 1999, Dr. Hammes joined the faculty at the University of Texas Southwestern Medical Center in Dallas, where he was a W W Caruth Scholar in Biomedical Research and Co-Director of the Endocrinology Fellowship Program. He moved to the University of Rochester in 2009 to become the Louis S Wolk Distinguished Professor of Medicine and the Chief of the Division of Endocrinology and Metabolism.
Dr. Hammes is interested in ovarian development and function. His laboratory studies steroid synthesis and actions in the ovary, with a focus on the pathophysiology of Polycystic Ovarian Syndrome. In addition, his lab studies androgen signaling in prostate cancer, focusing on nongenomic actions of androgens. Finally, he has an interest in lymphangioleiomyomatosis (LAM), a rare lung tumor that affects almost exclusively women. He has previously served as Editor-in-Chief of the journals Molecular Endocrinology and Endocrinology.
Disclosures:
No Relevant Financial Relationship
Mark Roberson, PhD(Speaker)
Cornell University College of Vet Medical
Dr. Roberson was raised in the Sierra Nevada region of Northern California and attended Cal Poly, San Luis Obispo, earning a BS degree in Animal Science. He earned his PhD from the University of Nebraska in Animal Physiology in 1990 with a focus on reproductive biology. He spent five years in postdoctoral training with Dr. Richard Maurer at the medical colleges at the University of Iowa, Iowa City, IA and then Oregon Health and Sciences University, Portland OR focusing on molecular endocrinology, GnRH action and gonadotropin gene regulation. Dr. Roberson was recruited to Cornell University College of Veterinary Medicine initially to the Department of Physiology in 1995 as an Assistant Professor. In 1999, this department merged to become the Department of Biomedical Sciences. In 2001, Dr. Roberson was appointed Associate Professor with indefinite tenure. In 2007, he was appointed Chair of Biomedical Sciences and Professor of Physiology; he served as Chair until 2017 when he stepped down to rejoin the research and teaching faculty. Dr. Roberson currently serves as Director of Undergraduate Studies in Animal Physiology Dr. Roberson has been funded by the NICHD and USDA and also served as PI and Director of an NICHD-funded T32 Training Program in Reproductive Sciences and Genomics. The Roberson lab focuses on molecular endocrine studies of the neuroendocrine axis controlling fertility and development studies of the murine and human placentas.
Disclosures:
No Relevant Financial Relationship
Individual Career Development Presentations – Part 2
Not Currently Available
Participants will report out and receive faculty feedback on their short-term and long-term goals.
E. Dale Abel, MD, PhD(Speaker)
University of Iowa
E. Dale Abel, MD, PhD is the Chair and Department Executive Officer of the Department of Internal Medicine and Director of the Fraternal Order of Eagles Diabetes Research Center (FOEDRC) at the University of Iowa. He is a Professor of Medicine, of Biochemistry, and of Biomedical Engineering, and holds the John B. Stokes III Chair in Diabetes Research and the François M. Abboud Chair in Internal Medicine. Dr. Abel has had a distinguished career in endocrine and metabolism research. His pioneering work on glucose transport and mitochondrial metabolism in the heart guides his current research interests: molecular mechanisms responsible for cardiovascular complications of diabetes. His laboratory has provided important insights into the contribution of mitochondrial dysfunction and aberrant insulin signaling, to heart failure risk in diabetes. Recent work has focused on mitochondrial mechanisms that mediate inter-organ crosstalk that may influence the pathophysiology of insulin resistance and mitochondrial pathways linking metabolism with increased risk for atherothrombosis. Dr. Abel’s research program has been continually funded by the National Institutes of Health since 1995, and by the American Heart Association, the American Diabetes Association, and the Juvenile Diabetes Research Foundation. Dr. Abel is the recipient of numerous awards for scholarship and mentorship. He is an elected member of the American Association of Physicians (AAP), the American Society for Clinical Investigation (ASCI), National Academy of Medicine (NAM), and the American Clinical and Climatological Association (ACCA). Dr. Abel is President-elect of the Association of Professors of Medicine (APM) and the Immediate Past President of the Endocrine Society.
Disclosures:
No Relevant Financial Relationship
Stephen Hammes, MD, PhD(Speaker)
University of Rochester
Dr. Hammes graduated with a degree in Chemistry from Cornell University in 1985. He then received his MD/PhD from Duke University. After that, he moved to the University of California in San Francisco, where he completed an internship and residency in General Medicine, followed by a clinical and research fellowship in Endocrinology.
In 1999, Dr. Hammes joined the faculty at the University of Texas Southwestern Medical Center in Dallas, where he was a W W Caruth Scholar in Biomedical Research and Co-Director of the Endocrinology Fellowship Program. He moved to the University of Rochester in 2009 to become the Louis S Wolk Distinguished Professor of Medicine and the Chief of the Division of Endocrinology and Metabolism.
Dr. Hammes is interested in ovarian development and function. His laboratory studies steroid synthesis and actions in the ovary, with a focus on the pathophysiology of Polycystic Ovarian Syndrome. In addition, his lab studies androgen signaling in prostate cancer, focusing on nongenomic actions of androgens. Finally, he has an interest in lymphangioleiomyomatosis (LAM), a rare lung tumor that affects almost exclusively women. He has previously served as Editor-in-Chief of the journals Molecular Endocrinology and Endocrinology.
Disclosures:
No Relevant Financial Relationship
Mark Roberson, PhD(Speaker)
Cornell University College of Vet Medical
Dr. Roberson was raised in the Sierra Nevada region of Northern California and attended Cal Poly, San Luis Obispo, earning a BS degree in Animal Science. He earned his PhD from the University of Nebraska in Animal Physiology in 1990 with a focus on reproductive biology. He spent five years in postdoctoral training with Dr. Richard Maurer at the medical colleges at the University of Iowa, Iowa City, IA and then Oregon Health and Sciences University, Portland OR focusing on molecular endocrinology, GnRH action and gonadotropin gene regulation. Dr. Roberson was recruited to Cornell University College of Veterinary Medicine initially to the Department of Physiology in 1995 as an Assistant Professor. In 1999, this department merged to become the Department of Biomedical Sciences. In 2001, Dr. Roberson was appointed Associate Professor with indefinite tenure. In 2007, he was appointed Chair of Biomedical Sciences and Professor of Physiology; he served as Chair until 2017 when he stepped down to rejoin the research and teaching faculty. Dr. Roberson currently serves as Director of Undergraduate Studies in Animal Physiology Dr. Roberson has been funded by the NICHD and USDA and also served as PI and Director of an NICHD-funded T32 Training Program in Reproductive Sciences and Genomics. The Roberson lab focuses on molecular endocrine studies of the neuroendocrine axis controlling fertility and development studies of the murine and human placentas.
Disclosures:
No Relevant Financial Relationship
Mentorship: When, Where, and What’s Next
Not Currently Available
Learn from an expert panel on how to select a good mentor, be a good mentee, change mentors with minimal conflict and become a strong mentor to others
Stanley Andrrisse, PhD, MBA(Panelist)
Howard University College of Medicine
Dr. Stanley Andrisse is a endocrinologist scientist and assistant professor at Johns Hopkins Medicine and
Howard University College of Medicine researching type 2 diabetes and insulin resistance. Dr. Andrisse
completed his Ph.D. at Saint Louis University and his M.B.A. and Bachelors degree at Lindenwood University,
where he played three years of Division II collegiate football.
Dr. Andrisse’s service commitments include: Executive Director and Founder of From Prison Cells to PhD,
past President of the Johns Hopkins Postdoctoral Association, Founder of the Diversity Postdoctoral Alliance,
member on several local and national committees aimed at community outreach, youth mentor, motivational
speaker, and community activist.
Dr. Andrisse was raised in Ferguson, MO. In his path, he made some poor decisions, encountered many road
blocks, took a few undesirable detours and pit-stops, but with resilience has made it to where he is now.
I will let him tell you more about himself. Without further ado, Dr. Stanley Andrisse.
Disclosures:
No Relevant Financial Relationship
Sherita Golden, MD(Panelist)
Johns Hopkins University Hospital
Dr. Sherita Hill Golden is the Hugh P. McCormick Family Professor of Endocrinology and Metabolism and Vice President and Chief Diversity Officer for Johns Hopkins Medicine. She holds joint appointments in the Welch Center for Prevention, Epidemiology, and Clinical Research, in the Department of Epidemiology at the Johns Hopkins Bloomberg School of Public Health, and in the Armstrong Institute for Patient Safety and Quality. She served as Director of the Johns Hopkins Hospital Inpatient Glucose Management Program from 2003-2018 and as Executive Vice-Chair of the Department of Medicine from 2015-2019. Dr. Golden graduated Phi Beta Kappa and summa cum laude from the University of Maryland, College Park and Alpha Omega Alpha from the University of Virginia School of Medicine before training in Internal Medicine and Endocrinology, Diabetes, and Metabolism at the Johns Hopkins Hospital. During her endocrinology fellowship she received a Master of Health Science degree in Clinical Epidemiology from the Johns Hopkins University Bloomberg School of Public Health where she was elected to the Delta Omega Public Health Honorary Society.
The author of more than 180 articles, Dr. Golden’s epidemiological research interests focus on two areas: (1) endogenous sex hormones as risk factors for CVD, type 2 diabetes, and insulin resistance in post-menopausal women and (2) mental health complications of diabetes and the biological, hormonal, and behavioral factors that might explain these associations. Her health services research focuses on understanding and eliminating diabetes health disparities and implementing and evaluating systems interventions to improve patient safety and quality of care in hospitalized patients with diabetes. She serves as the Principal Investigator of the Johns Hopkins site of the Diabetes Prevention Program Outcome Study and is an elected member of the American Society for Clinical Investigation and the Association of American Physicians. In 2017 she was the co-recipient of the Walter Reed Distinguished Achievement Award from the University of Virginia School of Medicine, Medical Alumni Association, and Medical School Foundation, which recognizes professional accomplishment, outstanding innovation, and exemplary leadership in the field of Medicine. In 2018 Dr. Golden was named a winner of the 17th Annual Women Worth Watching Awards from the Profiles in Diversity Journal. She was one of 132 winners from across the globe recognized as an executive leading the way to excellence in the workplace, marketplace and the world. Dr. Golden is also the recipient of the 2019 University of Virginia Distinguished Alumna Award and was named a 2020 Maryland Top 100 Woman. She is a devoted mentor and served as Director of the Epidemiology and Clinical Research in Diabetes and Endocrinology Training Grant from 2010-2019. She is a member of the American Diabetes Association National Board of Directors.
Disclosures:
No Relevant Financial Relationship
Antentor Hinton, Jr, PhD(Panelist)
University of Iowa
Dr. Antentor Hinton, Jr. is a Burroughs Wellcome Fund Postdoctoral Enrichment Scholar, EE Just Postgraduate Fellow in Life Sciences, and Ford Foundation Fellow at the University of Iowa in the laboratory of Dr. E. Dale Abel. Dr. Hinton seeks to elucidate the mechanisms by which insulin signaling regulates Optic Atrophy 1 Protein activity in skeletal muscle, heart, and brain. Dr. Hinton received his B.S. in Biology from Winston-Salem State University and his NIH postbac and Ph.D. at Baylor College of Medicine in Integrative Molecular and Biomedical Sciences. To date, Dr. Hinton has published 26 papers, gleaned 50 awards, and given 75 invited talks. Dr. Hinton has mentored 45 graduate, medical, or undergraduate students and he has been awarded three University-wide awards and an organizational mentorship award, the Iowa Center for Research by Undergraduates Distinguished Mentoring Award, Center for Diversity & Enrichment’s Distinguished Educator Award, Diversity Catalyst Award, and an LSAMP Excellence in Mentoring Award. From all of these efforts around diversity, Hinton has recognized by Forbes Magazines as one of the 100 Black Culture Makers and Thought- Leaders. This honor was also featured in the 2020 Inaugural Year of the Digital Book Celebrating 100 Black Culture Makers and Thought-Leaders. Notably, Hinton has recently secured a Visiting Postdoctoral Fellow Appointment at Mayo Clinic, where he will conduct research in collaboration with Dr. Jeffrey Salisbury. Dr. Salisbury is a world-renowned cell biologist who runs Mayo’s Central Microscopy Core; under his mentorship, Hinton will advance his training in Serial Block-Face Scanning Electron Microscopy (SBF-SEM) and Transmission Electron Microscopy Quantification. Summer 2021, Dr. Antentor Hinton, Jr. will matriculate to a tenure track Assistant Professor Position in the Department of Molecular Physiology and Biophysics at Vanderbilt University.
Dr. Hinton’s United Negro College Fund/ Bristol Myers Squibs Funded Project and NIH funded Project aim to elucidate insulin-mediated molecular mechanisms that regulate cristae dynamics and elucidate molecular mechanisms that regulate molecule transfer and morphology changes between the mitochondria, and the endoplasmic reticulum can alter during a pathophysiological state, such as Diabetes or Cardiovascular Disease.
Dr. Hinton is an active member of the Endocrine Society and a 2015 FLARE Fellow.
Disclosures:
No Relevant Financial Relationship
Demystifying the Job Search and Negotiations
Not Currently Available
Learn how to build an effective resume/CV and tips on acing an interview for postdoctoral or research fellowship positions. Learn how to negotiate for faculty positions around items such as salary, benefits, lab space, equipment, staff, contract details, and teaching vs. research requirements.
Dequina Nicholas, PhD(Speaker)
University of California, Irvine
Dr. Dequina Nicholas is a new Assistant Professor at the University of California Irvine in the Department of Molecular Biology and Biochemistry starting July 2021. Her work focuses on how the immune system and cellular metabolism impacts endocrine diseases, particularly type 2 diabetes and polycystic ovary syndrome. Dr. Nicholas received her PhD in biochemistry from Loma Linda University and pursued additional postdoctoral training in the laboratory of Dr. Barbara Nikolajczyk at Boston University, studying the metabolism of immune cells from patients with type 2 diabetes. While finishing her current position as a postdoctoral fellow at the University of California San Diego, Dequina is investigating the impact of inflammation and metabolism on reproduction. Dr. Nicholas is excited to build her “immunoendocrine” lab and train the next generation of scientists. She has a passion for fitness and enjoys mentoring, especially first-generation students like herself on their scientific journey.
Disclosures:
No Relevant Financial Relationship
Cecilia Low Wang, MD(Speaker)
University Colorado Anschutz Medical Campus
Cecilia C. Low Wang, MD, is Professor of Medicine at the University of Colorado Anschutz Medical
Campus School of Medicine, Director of the Glucose Management Team at the University of Colorado
Hospital, Director of the CU Diabetes Fellowship Training Program, and Clinician-Scientist at CPC Clinical
Research. Dr. Low Wang teaches medical students, housestaff, fellows and physicians in a variety of
different settings and gives presentations to physicians, advanced practice providers, and trainees
(housestaff, medical students, fellows) on topics ranging from endocrine issues in women and diabetes
management in a variety of clinical situations to lipid disorders, obesity, thyroid disorders and
osteoporosis. She has strong clinical interests in hospital diabetes/hyperglycemia, transitions of care,
complications of diabetes, insulin resistance, and lifestyle management for metabolic disease. She sees
patients on the Glucose Management Team and Endocrinology consult services at the University of
Colorado Hospital (UCH), and sees patients in the UCH Endocrine and Diabetes Clinic with a focus on
diabetes and metabolic disorders. She is a member of the Clinical Endocrine Update Core Committee
and of the Nominating Committee of the Endocrine Society. She served on the Strategic Plan 4 Task
Force and previously served on the Trainee and Career Development Core Committee, Research Affairs
Core Committee Clinical Research Subcommittee and the Scientific and Educational Programs Core
Committee. Dr. Low Wang is involved in clinical trials through CPC Clinical Research, an academic clinical
research organization. She previously served on the Endocrinologic and Metabolic Drugs Advisory
Committee for the Food and Drug Administration. Her current clinical research interests include
diabetes and cardiovascular disease, hospital use of diabetes technology, hospital dysglycemia,
community-based pragmatic trials in diabetes and cardio-oncology, and stem cell therapy for diabetic
foot ulcer.
Disclosures:
No Relevant Financial Relationship
Mock Study Section
Not Currently Available
Gain insight into the grant review process. Learn tips from the experts on what reviewers look for in a successful grant application.
Stephen Hammes, MD, PhD(Panelist)
University of Rochester
Dr. Hammes graduated with a degree in Chemistry from Cornell University in 1985. He then received his MD/PhD from Duke University. After that, he moved to the University of California in San Francisco, where he completed an internship and residency in General Medicine, followed by a clinical and research fellowship in Endocrinology.
In 1999, Dr. Hammes joined the faculty at the University of Texas Southwestern Medical Center in Dallas, where he was a W W Caruth Scholar in Biomedical Research and Co-Director of the Endocrinology Fellowship Program. He moved to the University of Rochester in 2009 to become the Louis S Wolk Distinguished Professor of Medicine and the Chief of the Division of Endocrinology and Metabolism.
Dr. Hammes is interested in ovarian development and function. His laboratory studies steroid synthesis and actions in the ovary, with a focus on the pathophysiology of Polycystic Ovarian Syndrome. In addition, his lab studies androgen signaling in prostate cancer, focusing on nongenomic actions of androgens. Finally, he has an interest in lymphangioleiomyomatosis (LAM), a rare lung tumor that affects almost exclusively women. He has previously served as Editor-in-Chief of the journals Molecular Endocrinology and Endocrinology.
Disclosures:
No Relevant Financial Relationship
Yvette Huet, PhD(Panelist)
University of North Carolinia, Charlotte
Dr. Huet is the Director for the UNC Charlotte ADVANCE Faculty Affairs and Diversity Office and a Professor of Kinesiology. She is the UNC Charlotte PI of a 2018 NSF AGEP award -AGEP NC. Her current research interests include women and students and faculty of color in the academy; disparities in health outcomes by sex. Dr. Huet earned her B.S. in Human Biology: Microbiology from the University of Kansas; her Ph.D. (with Honors) in physiology from the University of Kansas Medical Center; and had a Postdoctoral Fellowship with Monsanto Company in Missouri. Her honors include a National Science Foundation Minority Graduate Fellowship and a Ford Foundation Dissertation Fellowship for Minorities. She has served in many other leadership roles at UNC Charlotte, including as Coordinator of Faculty Development, College of Liberal Arts & Sciences and Interim Chair, Kinesiology.
Disclosures:
No Relevant Financial Relationship
Chad Hunter, PhD(Panelist)
University of Alabama at Birmingham
Dr. Hunter earned his Ph.D. from Purdue University from 2002-2007 through studies of transcription factor control of pituitary gene regulation. From 2007-2013, he was a postdoctoral fellow at Vanderbilt University and studied transcriptional regulation of pancreatic islet cell development and function. In 2014, Dr. Hunter was recruited to the Division of Endocrinology, Diabetes and Metabolism at the University of Alabama at Birmingham (UAB) Department of Medicine where he is now a tenured Associate Professor. In addition to continued studies of pancreatic islets, Dr. Hunter has a keen interest in fostering the next generation of scientists through mentoring of trainees, reviewing NIH career development awards, and through promoting research development at UAB.
Disclosures:
No Relevant Financial Relationship
Genevieve Neal-Perry, MD, PhD(Panelist)
University of North Carolina at Chapel Hill
Dr. Neal-Perry received her Bachelor of Arts in Biology from Dartmouth College in 1988 and her MD PhD in Pharmacology from Robert Wood Johnson Medical School in 1998. She completed an Obstetrics and Gynecology residency at Beth Israel Medical Center in New York City, the Manhattan Campus for Einstein College of Medicine in 2002, and a subspecialty fellowship in Reproductive Endocrinology and Infertility (REI) at Montefiore Medical Center and Einstein College of Medicine in 2005. Dr. Neal-Perry was the Director of the REI fellowship training program (2011-2015) and the Associate Dean for Diversity Mentoring (2010-2015) while at Einstein College of Medicine. She moved to the University of Washington to join the department of Obstetrics and Gynecology in February 2015. While at the University of Washington, Dr. Neal-Perry served as the Division Chief for REI and the Section Director of the Onco-Reproduction Unit. Dr. Neal-Perry joined the University of North Carolina School of Medicine in April 20220 to serve as the Robert A. Ross Distinguished Professor and Chair of Obstetrics and Gynecology.
Dr. Neal-Perry is a leader in women’s healthcare and reproductive science. She serves as an ad hoc reviewer for more than 20 journals and she is an editorial board member for Endocrinology. She directs basic science as well as clinical research that is focused on the effect of age, hormones, metabolism and nutrition on neuroendocrine function, the pubertal and menopausal transition and the modifiers of menopause-related symptoms. She has published multiple original research articles, research abstracts, book chapters and review articles with her mentees and scientific peers. Her research has been recognized by Faculty of 1000 as important contributions to scientific literature (2009 and 2015). She was funded by Robert Wood Johnson Foundation, NIH, SREI, ASRM, the American Federation for Aging Research, and other private foundations. Dr. Neal-Perry’s current research program is funded by the NICHD and private foundations. She currently serves as the PI of the Women’s Reproductive Health Research Grant, a highly coveted NIH Mentored Research Scientist Development Program Award (K12) mechanism for physicians who have trained in Obstetrics and Gynecology.
Dr. Neal-Perry is currently the Vice President, Basic Science (2016-2019), for The Endocrine Society and a board member for the Division of Reproductive Endocrinology and Infertility of the American Board of Obstetrics and Gynecology. She is standing member of the NICHD Reproduction Andrology and Gynecology (2017-2021) study section and previously served as member of the Integrative Clinical Endocrinology and Reproduction (2012-2018) study section. She is currently the Vice President of Diversity and Structural Change for the Society of Reproductive Investigations and a member of the National Advisory Child Health and Human Development Council.
Dr. Neal-Perry is passionate about medical education and training of the next generation of clinicians and scientists. She has mentored high school through junior faculty mentees. Her mentees have successfully competed for independent grants and their research has been selected for plenary presentations at American Reproductive Society of Medicine and the Society of Reproductive Investigations. Dr. Neal-Perry has received mentor awards from the American Medical Women’s Association as well as the Endocrine Society.
Disclosures:
No Relevant Financial Relationship
Time Management and Life Balance: Juggling Multiple Priorities
Not Currently Available
Gain practical advice on how to manage your time in and out of the lab. Discover the secrets to work-life balance and redefine career success.
Antentor Hinton, Jr, PhD
University of Iowa
Dr. Antentor Hinton, Jr. is a Burroughs Wellcome Fund Postdoctoral Enrichment Scholar, EE Just Postgraduate Fellow in Life Sciences, and Ford Foundation Fellow at the University of Iowa in the laboratory of Dr. E. Dale Abel. Dr. Hinton seeks to elucidate the mechanisms by which insulin signaling regulates Optic Atrophy 1 Protein activity in skeletal muscle, heart, and brain. Dr. Hinton received his B.S. in Biology from Winston-Salem State University and his NIH postbac and Ph.D. at Baylor College of Medicine in Integrative Molecular and Biomedical Sciences. To date, Dr. Hinton has published 26 papers, gleaned 50 awards, and given 75 invited talks. Dr. Hinton has mentored 45 graduate, medical, or undergraduate students and he has been awarded three University-wide awards and an organizational mentorship award, the Iowa Center for Research by Undergraduates Distinguished Mentoring Award, Center for Diversity & Enrichment’s Distinguished Educator Award, Diversity Catalyst Award, and an LSAMP Excellence in Mentoring Award. From all of these efforts around diversity, Hinton has recognized by Forbes Magazines as one of the 100 Black Culture Makers and Thought- Leaders. This honor was also featured in the 2020 Inaugural Year of the Digital Book Celebrating 100 Black Culture Makers and Thought-Leaders. Notably, Hinton has recently secured a Visiting Postdoctoral Fellow Appointment at Mayo Clinic, where he will conduct research in collaboration with Dr. Jeffrey Salisbury. Dr. Salisbury is a world-renowned cell biologist who runs Mayo’s Central Microscopy Core; under his mentorship, Hinton will advance his training in Serial Block-Face Scanning Electron Microscopy (SBF-SEM) and Transmission Electron Microscopy Quantification. Summer 2021, Dr. Antentor Hinton, Jr. will matriculate to a tenure track Assistant Professor Position in the Department of Molecular Physiology and Biophysics at Vanderbilt University.
Dr. Hinton’s United Negro College Fund/ Bristol Myers Squibs Funded Project and NIH funded Project aim to elucidate insulin-mediated molecular mechanisms that regulate cristae dynamics and elucidate molecular mechanisms that regulate molecule transfer and morphology changes between the mitochondria, and the endoplasmic reticulum can alter during a pathophysiological state, such as Diabetes or Cardiovascular Disease.
Dr. Hinton is an active member of the Endocrine Society and a 2015 FLARE Fellow.
Disclosures:
No Relevant Financial Relationship
Advancing Leadership Diversity
Not Currently Available
This session will address systemic issues faced by underrepresented minority scientists such as implicit bias and systemic racism while teaching solutions to help overcome microaggressions and other types of difficult situations
Sherri-Ann Burnett-Bowie, MD, MPH
Massachusetts General Hospital
Dr. Burnett-Bowie is an Assistant Professor of Medicine at Harvard Medical School (HMS) and a clinical investigator in the Mass General Hospital Endocrine Division, where she is the site principal investigator for the SWAN Study, a multi-site, 24-year longitudinal study of menopause. Promoting diversity and inclusion is her core mission and shapes her educational focus and administrative roles. Dr. Burnett-Bowie is the Director of Multicultural Affairs for the MGH Department of Medicine, where she is leading the Department of Medicine’s Anti-Racism Strategy.
Disclosures:
No Relevant Financial Relationship
